EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSLUG00000023215
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSSLUG00000025708
Gene Symbol: HMGCR
3 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSSLUG00000014926
Gene Symbol: LOC116063008
3 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSSLUG00000016409
Gene Symbol: LOC116048133
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSSLUG00000014406
Gene Symbol: PDPK1
3 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSSLUG00000009130
Gene Symbol: HPDB
1 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSSLUG00000008587
Gene Symbol: LOC116065970
3 Cross references
31 Possible Orthologues:

40s Ribosomal Protein Sa

Ensembl ID : ENSSLUG00000016225
Gene Symbol: LOC116046724
3 Cross references
515 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSSLUG00000021826
Gene Symbol: NT5E
3 Cross references
215 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSSLUG00000018779
Gene Symbol: NT5E
1 Cross references
180 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSSLUG00000025949
Gene Symbol: HTR2B
1 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSSLUG00000008836
Gene Symbol: HTR2CL1
1 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).